Detalhe da pesquisa
1.
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.
Blood
; 141(26): 3166-3183, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084385
2.
Health-related quality of life in patients with hematologic malignancies treated with chimeric antigen receptor T-cell therapy: review and current progress.
Haematologica
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450528
3.
Lymphocyte migration and retention properties affected by ibrutinib in chronic lymphocytic leukemia.
Haematologica
; 109(3): 809-823, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381758
4.
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study.
Ann Hematol
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443660
5.
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(12): 1423-1433, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944541
6.
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Blood
; 137(25): 3495-3506, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598678
7.
A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial.
Blood
; 137(8): 1019-1023, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33167024
8.
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031755
9.
Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.
Cancer
; 128(3): 519-528, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605020
10.
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier.
Blood
; 135(13): 996-1007, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977002
11.
Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma.
Haematologica
; 107(1): 221-230, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33327711
12.
Does early disease progression predict survival after first line-treatment of Waldenström macroglobulinemia?
Hematol Oncol
; 40(3): 400-408, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385885
13.
Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.
Proc Natl Acad Sci U S A
; 116(24): 11906-11915, 2019 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118283
14.
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
N Engl J Med
; 379(10): 934-947, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184451
15.
Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study.
Blood
; 134(7): 641-644, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243043
16.
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.
Blood
; 133(26): 2765-2775, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862645
17.
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.
Haematologica
; 106(1): 87-97, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974198
18.
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
Ann Hematol
; 100(4): 987-993, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495922
19.
Impact of a comprehensive geriatric assessment on decision-making in older patients with hematological malignancies.
Eur J Haematol
; 106(5): 616-626, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340150
20.
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.
BMC Public Health
; 21(1): 432, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653294